These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24729124)

  • 21. Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers.
    Lin SC; Chang IW; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Tian YF
    J Cancer; 2017; 8(14):2756-2764. PubMed ID: 28928864
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy].
    Cai C; Wang J; Zhong Z; Dai Z; Wang Q; Dong W; Shi H; Liu Q; DU J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 46(1):36-43. PubMed ID: 28436629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.
    Lin CY; Lin CY; Chang IW; Sheu MJ; Li CF; Lee SW; Lin LC; Lee YE; He HL
    Am J Transl Res; 2015; 7(11):2423-32. PubMed ID: 26807188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.
    Chen TJ; Chou CL; Tian YF; Yeh CF; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
    Int J Clin Oncol; 2021 Sep; 26(9):1689-1697. PubMed ID: 34043102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
    Tian YF; Hsieh PL; Lin CY; Sun DP; Sheu MJ; Yang CC; Lin LC; He HL; Solórzano J; Li CF; Chang IW
    J Cancer; 2017; 8(7):1197-1204. PubMed ID: 28607594
    [No Abstract]   [Full Text] [Related]  

  • 27. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT.
    Chou CL; Chen TJ; Tian YF; Chan TC; Yeh CF; Li WS; Tsai HH; Li CF; Lai HY
    Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Lee SJ; Kim JG; Lee SW; Chae YS; Kang BW; Lee YJ; Park JS; Choi GS
    Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of KRAS Mutations on the Prognosis of Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Surgery.
    Park JS; Lee SS; Choi YS
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2337-2342. PubMed ID: 39068566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.
    Tian YF; Chen TJ; Lin CY; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Shiue YL; Huang HY; Pan HY; Li CF; Chen SH
    Tumour Biol; 2013 Apr; 34(2):1107-17. PubMed ID: 23328995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
    Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
    Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VNN1 overexpression is associated with poor response to preoperative chemoradiotherapy and adverse prognosis in patients with rectal cancers.
    Chai CY; Zhang Y; Song J; Lin SC; Sun S; Chang IW
    Am J Transl Res; 2016; 8(10):4455-4463. PubMed ID: 27830030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim E; Kim K; Oh H; Han SW; Kim TY; Jung SY; Park KJ; Kang GH; Chie EK
    J BUON; 2019; 24(2):470-478. PubMed ID: 31127993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis.
    Chou CL; Chen TJ; Lin CY; Lee SW; Wang SC; Chu SS; Yang CC
    Onco Targets Ther; 2020; 13():3141-3150. PubMed ID: 32346297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients.
    Chen TJ; Hsu BH; Lee SW; Yang CC; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Chou CL; Lai HY
    Pathol Oncol Res; 2022; 28():1610537. PubMed ID: 36277959
    [No Abstract]   [Full Text] [Related]  

  • 38. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
    Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
    Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy.
    Su YT; Chen CH; Kang JW; Kuo HY; Yang CC; Tian YF; Yeh CF; Chou CL; Chen SH
    Aging (Albany NY); 2024 May; 16(9):7889-7901. PubMed ID: 38709264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy.
    Chou CL; Chen TJ; Li WS; Lee SW; Yang CC; Tian YF; Lin CY; He HL; Wu HC; Shiue YL; Li CF; Kuo YH
    Onco Targets Ther; 2022; 15():1171-1181. PubMed ID: 36238133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.